SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Feb 4, 2020

Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: Feb. 4, 2020 · CIK: 0001723069 · Accession: 0001213900-20-002591

AI Filing Summary & Sentiment

File numbers found in text: 333-236013

Date
Feb. 4, 2020
Author
Not clearly detected
Form
CORRESP
Company
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)

Letter

Tiziana Life Sciences plc

3rd Floor

11-12 St. James’s Square

London SW1Y 4LB

United Kingdom

February 4, 2020

VIA EDGAR

United States Securities

and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey Gabor

Re: Tiziana Life Sciences plc

Registration Statement on Form S-3, as amended

File No. 333-236013

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Tiziana Life Sciences Plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Standard Time, on Thursday, February 6, 2020, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Thank you,

TIZIANA LIFE SCIENCES PLC

By: /s/ Kunwar Shailubhai

Name: Kunwar Shailubhai

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Tiziana
Life Sciences plc

3rd Floor

11-12 St. James’s Square

London SW1Y 4LB

United Kingdom

                      February
4, 2020

VIA EDGAR

United States Securities

and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention:
Jeffrey Gabor

     Re:
    Tiziana Life Sciences plc

    Registration Statement on Form S-3, as amended

    File No. 333-236013

Ladies and Gentlemen:

Pursuant to
Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Tiziana
Life Sciences Plc (the “Company”) respectfully requests that the effective date of the registration statement
referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Standard Time, on Thursday, February
6, 2020, or as soon thereafter as possible.

Please notify Jeffrey
Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Thank you,

    TIZIANA LIFE SCIENCES PLC

    By:
    /s/ Kunwar Shailubhai

    Name:
    Kunwar Shailubhai

    Title:
    Chief Executive Officer